IBJNews

Pace of life sciences venture capital deals in Indiana picks up

Back to TopCommentsE-mailPrintBookmark and Share
On The Beat Industry News In Brief

After no Indiana health and life sciences firms announced venture capital deals in the second quarter, five did so in the third, and two more have already this month.

That’s equal to the number of companies attracting investment in the first quarter, but the value per deal grew from more than $4 million to more than $5 million, according to data from BioEnterprise, a Cleveland-based life sciences business development group.

The companies securing investments in the third quarter were Dormir LLC, Carmel, an operator of sleep centers: $12 million; Nico Corp., Indianapolis, a developer of technology for minimally invasive neurosurgery: $10 million; Diagnostic ID, Indianapolis, a maker of a system that matches patients with their biopsy samples: $3 million; Matrix-Bio, West Lafayette, a maker of a blood test for early-stage detection of breast cancer: $200,000; and FAST Diagnostics, Indianapolis, a maker of a kidney filtering monitor: $150,000.

In October, Warsaw-based OrthoPediatrics shared an undisclosed portion of $1.4 million handed out by StepStone Angels, an Indianapolis-based group of private investors. Also, West Lafayette-based developer of cancer drugs Endocyte Inc. pulled in a whopping $26 million from its investors.

Even with that deal, the average size of investment is about half what it was a year ago, and even less than in 2007, before the recession took hold.

Health-care-related venture capital deals in other Midwestern states have also increased in number this year, but decreased in size, according to BioEnterprise.

ADVERTISEMENT

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. By Mr. Lee's own admission, he basically ran pro-bono ads on the billboard. Paying advertisers didn't want ads on a controversial, ugly billboard that turned off customers. At least one of Mr. Lee's free advertisers dropped out early because they found that Mr. Lee's advertising was having negative impact. So Mr. Lee is disingenous to say the city now owes him for lost revenue. Mr. Lee quickly realized his monstrosity had a dim future and is trying to get the city to bail him out. And that's why the billboard came down so quickly.

  2. Merchants Square is back. The small strip center to the south of 116th is 100% leased, McAlister’s is doing well in the outlot building. The former O’Charleys is leased but is going through permitting with the State and the town of Carmel. Mac Grill is closing all of their Indy locations (not just Merchants) and this will allow for a new restaurant concept to backfill both of their locations. As for the north side of 116th a new dinner movie theater and brewery is under construction to fill most of the vacancy left by Hobby Lobby and Old Navy.

  3. Yes it does have an ethics commission which enforce the law which prohibits 12 specific items. google it

  4. Thanks for reading and replying. If you want to see the differentiation for research, speaking and consulting, check out the spreadsheet I linked to at the bottom of the post; it is broken out exactly that way. I can only include so much detail in a blog post before it becomes something other than a blog post.

  5. 1. There is no allegation of corruption, Marty, to imply otherwise if false. 2. Is the "State Rule" a law? I suspect not. 3. Is Mr. Woodruff obligated via an employment agreement (contractual obligation) to not work with the engineering firm? 4. In many states a right to earn a living will trump non-competes and other contractual obligations, does Mr. Woodruff's personal right to earn a living trump any contractual obligations that might or might not be out there. 5. Lawyers in state government routinely go work for law firms they were formally working with in their regulatory actions. You can see a steady stream to firms like B&D from state government. It would be interesting for IBJ to do a review of current lawyers and find out how their past decisions affected the law firms clients. Since there is a buffer between regulated company and the regulator working for a law firm technically is not in violation of ethics but you have to wonder if decisions were made in favor of certain firms and quid pro quo jobs resulted. Start with the DOI in this review. Very interesting.

ADVERTISEMENT